Company profile for CARGO Therapeutics

NEW Drugs in Dev: 3
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies.Despite advances made by commercially available autologous CARs, these treatments...
CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies.Despite advances made by commercially available autologous CARs, these treatments are curative for fewer than half of all cancer patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1900 Alameda De Las Pulgas Suite 350 San Mateo, CA 94403
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/business/concentra-snags-another-struggling-biotech-as-cargo-accepts-200m-buyout

BIOSPACE
09 Jul 2025

https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-reports-fourth-quarter-and-full-year-2023

PRESS RELEASE
21 Mar 2024

https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-participate-44th-annual-cowen-healthcare

PRESS RELEASE
29 Feb 2024

https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-present-42nd-annual-jp-morgan-healthcare

PRESS RELEASE
03 Jan 2024
Cargo, undeterred by market challenges, seeks $281M IPO
Cargo, undeterred by market challenges, seeks $281M IPO

10 Nov 2023

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/cargo-undeterred-market-challenges-seeks-281m-ipo

Annalee Armstrong FIERCE BIOTECH
10 Nov 2023

https://endpts.com/cargo-therapeutics-eyes-one-of-2023s-largest-ipos-in-a-dull-year-for-listings/

Kyle LaHucik ENDPTS
06 Nov 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty